(Q30559082)

24 June 2017

title

Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins (English)

1 reference

24 June 2017

1 reference

Becket G

1

1 reference

24 June 2017

Schep LJ

series ordinal

2

1 reference

24 June 2017

Tan MY

series ordinal

3

1 reference

24 June 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

International Journal of Pharmaceutics

24 June 2017

published in

1 reference

24 June 2017

volume

179

1 reference

24 June 2017

issue

1

1 reference

24 June 2017

page(s)

65-71

1 reference

Praziquantel: mechanisms of anti-schistosomal activity

24 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2898%2900382-2

7 January 2021

Molecular complexation: beta-cyclodextrin and benzaldehyde inclusion complex

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2898%2900382-2

7 January 2021

Mechanism of drug dissolution rate enhancement from β-cyclodextrin-drug systems

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2898%2900382-2

7 January 2021

Estimation of dissolution rate of salicylamide in complexing media using a theoretical diffusion model

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2898%2900382-2

7 January 2021

Interactions of .ALPHA.- and .BETA.-cyclodextrin with several non-steroidal antiinflammatory drugs in aqueou solution

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2898%2900382-2

7 January 2021

Drugs five years later: praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2898%2900382-2

7 January 2021

Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with .ALPHA.- and .BETA.-cyclodextrins in powdered form

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2898%2900382-2

7 January 2021

Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2898%2900382-2

7 January 2021

Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2898%2900382-2

7 January 2021

Bioavailability of powdered inclusion compounds of nonsteroidal antiinflammatory drugs with beta-cyclodextrin in rabbits and dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2898%2900382-2

7 January 2021

Study of the interaction between beta-cyclodextrin and chlorhexidine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2898%2900382-2

7 January 2021

Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2898%2900382-2

7 January 2021

10.1016/S0378-5173(98)00382-2

Identifiers

DOI

1 reference

24 June 2017

1 reference